1057.1000 26.95 (2.62%)
NSE Nov 16, 2026 15:31 PM
Volume: 452.1K
 

Deven Choksey
Alembic Pharma is expected to maintain steady growth momentum supported by its expanding complex generics portfolio in the US, sustained traction in Ex-US markets, and a gradual recovery in the domestic formulations business.
Alembic Pharmaceutic.. has an average target of 898.00 from 3 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended